OUR PIPELINE

We are a global team of scientists wholly dedicated to the study of cancer. Our focus in drug development is on disease pathways — or processes — that cancer cells depend on to survive. View pathways we are focusing on.

We have more than 300 projects under way and more than 15 drug candidates in our pipeline. Explore a representation of our pipeline below to learn more. Download a PDF version of the pipeline.

ONCOLOGY DEVELOPMENT PIPELINE

* VELCADE® is co-developed by Millennium and Johnson & Johnson Pharmaceutical Research & Development

In-Licensed

SGN-35 is co-developed by Millennium and Seattle Genetics, Inc.

** Castration Resistant Prostate Cancer

§ Japan only development and marketing

All registered trademarks are the sole property of their respective owners. 1/16/13